When was Cleveland Diagnostics founded?

Cleveland Diagnostics was founded in 2013 and raised its 1st funding round 2 years after it was founded.

Where is Cleveland Diagnostics located?

Cleveland Diagnostics is headquartered in Cleveland, United States.

How many employees does Cleveland Diagnostics have?

As of Sep 30, 2026, the latest employee count at Cleveland Diagnostics is 112.

Is Cleveland Diagnostics a funded company?

Cleveland Diagnostics is a funded company, having raised a total of $111M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 03, 2015.

When was the latest funding round of Cleveland Diagnostics?

Cleveland Diagnostics' latest funding was a $***** Series E round on Oct 07, 2025, with participation from 0 investor.

Where does Cleveland Diagnostics rank among its competitors?

Cleveland Diagnostics ranks 34th amongst 753 active competitors, of which 227 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was 4baseCare, which secured an undisclosed amount in Jul, 2026.

Who are the top competitors of Cleveland Diagnostics?

Cleveland Diagnostics' top competitors include Guardant Health, Natera and Foundation Medicine. Among them, 4baseCare secured the most recent funding round in July, 2026.

Cleveland Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Company Details

ClevelandDx has developed diagnostics technology to detect cancer in early-stage. The company uses specific biomarkers to distinguish the non-cancerous and cancerous conditions. The expression of these biomarkers is based on a proprietary technology that separates protein isoforms, based on structure.

Website: www.clevelanddx.com/
Email ID: *****@clevelanddx.com
Phone Number: +1 **********

Key Metrics

Founded Year

2013

Location

Cleveland, United States

Stage

Series E

Total Funding

$111M in 6 rounds

Latest Funding Round

Series E, Oct 07, 2025, $*****

Investors

LYFE Capital & 6 more

Ranked

34^th among 753 active competitors

Employee Count

112 as on Sep 30, 2026

Similar Companies

Guardant Health & 1007 more

View Cleveland Diagnostics' full profile

Cleveland Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Reports
Cleveland Diagnostics, Inc. CIN: 463916837 , United States, Active	Jul 09, 2019	-	86 (As on Dec 31, 2024)	-

Cleveland Diagnostics has raised a total funding of $111M over 6 rounds. Its first funding round was on Mar 03, 2015. Cleveland Diagnostics has 7 institutional investors.

Here is the list of recent funding rounds of Cleveland Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 07, 2025	4593332	Series E	1011993	2875839	7578623	6020398
Jan 17, 2024	1345292	Series E	9342701	5677998	6074119	3295187
Feb 09, 2021	4042139	Series D	4533968	6201583	LYFE Capital	Cleveland Clinic

Access funding benchmarks and valuations. Sign up today!

View details of Cleveland Diagnostics's funding rounds and investors

The founders of Cleveland Diagnostics is Boris Zaslavsky.

Here are the details of Cleveland Diagnostics' key team members:

Boris Zaslavsky: Co-Founder of Cleveland Diagnostics and founder of 2 other companies, AnalizaDx and Cleveland Diagnostics.
Contact Info: 1 email address

View details of Cleveland Diagnostics's Founder profiles and Board Members

Cleveland Diagnostics' employee count trend

Cleveland Diagnostics has 112 employees as of Sep 26. Here is Cleveland Diagnostics's employee count trend over the years:

Employee count trend for Cleveland Diagnostics

Uncover Cleveland Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cleveland Diagnostics include Guardant Health, Natera and Foundation Medicine. Here is the list of Top 10 competitors of Cleveland Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Guardant Health 2012, Redwood City (United States), Public	Developer of digital sequencing technology for cancer detection	$557M	SoftBank Vision Fund, Lightspeed Venture Partners ... & 25 others	79/100
2nd	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Bain Capital Life Sciences ... & 18 others	77/100
3rd	Foundation Medicine 2010, Cambridge (United States), Acquired	Provider of genomics-based diagnostics test for cancer	$96.5M	Redmile Group, Deerfield & 11 others	70/100
4th	Prenetics 2009, Hong Kong (China), Public	Online platform for genetic and diagnostic health testing that helps identify health risks	$67.6M	Apis Partners, Beyond Ventures & 22 others	69/100
5th	BillionToOne 2015, San Francisco (United States), Public	Provider of cell-free cancer liquid biopsy test	$389M	Hummingbird Ventures, Adams Street Partners ... & 31 others	69/100
6th	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	68/100
7th	Geneoscopy 2015, St. Louis (United States), Series C	Developer of non-invasive biomarker tests for colorectal cancer	$219M	LightChain Capital, Cultivation Capital & 18 others	67/100
8th	4baseCare 2018, Bengaluru (India), Series B	Provider of precision oncology solutions, including genomic testing and digital health	$25.9M	Tremis Consultancy, Yali Capital & 41 others	67/100
9th	Caris Life Sciences 1996, Irving (United States), Public	Developer of panomic disease profiling technologies for cancer precision medicine	$1.23B	Sixth Street, Coatue & 19 others	66/100
10th	Intellia Therapeutics 2014, Cambridge (United States), Public	Developer of therapeutics based on CRISPR/Cas9 technology for multiple diseases	$85M	Atlas Venture, Novartis & 10 others	66/100
34th	Cleveland Diagnostics 2013, Cleveland (United States), Series E	Developer of diagnostics technology to detect cancer in early stage	$111M	LYFE Capital, Novo Holdings & 5 others	60/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Cleveland Diagnostics's competitors? Click here to see the top ones

Cleveland Diagnostics has made no investments or acquisitions yet.

Here is the latest report on Cleveland Diagnostics's sector:

Free

Oncology - Sector Report

Edition: August, 2026 (74 Pages)

View all reports related to Cleveland Diagnostics

Media has covered Cleveland Diagnostics for a total of 6 events in the last 1 year, 3 of them have been about people movement and 2 about company updates.